- Home
- VFL vs TMCI Comparison
VFL vs TMCI Comparison
Compare VFL & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VFL | TMCI |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.7M | 120.4M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VFL | TMCI |
|---|---|---|
| Price | $10.20 | $1.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.77 |
| AVG Volume (30 Days) | 28.9K | ★ 783.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $212,690,000.00 |
| Revenue This Year | N/A | $0.87 |
| Revenue Next Year | N/A | $8.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $9.27 | $1.31 |
| 52 Week High | $10.50 | $8.84 |
Technical Indicators
Market Signals| Indicator | VFL | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 29.99 | 37.03 |
| Support Level | $10.16 | N/A |
| Resistance Level | $10.32 | $3.06 |
| Average True Range (ATR) | 0.06 | 0.17 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 0.00 | 33.15 |
Price Performance
Historical ComparisonAbout VFL abrdn National Municipal Income Fund
Delaware Investments Natl Muni Income is a closed-end investment fund. The Fund's investment objective is to seek to provide current income exempt from regular federal income tax, consistent with the preservation of capital. The company's product portfolio includes Mutual funds, Exchange-traded funds, Private markets, and Closed-end funds.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.